Revelation Biosciences Inc (REVB)

Currency in USD
2.519
+0.019(+0.75%)
Real-time Data·
REVB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
REVB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4202.600
52 wk Range
2.106168.000
Key Statistics
Prev. Close
2.5
Open
2.421
Day's Range
2.42-2.6
52 wk Range
2.106-168
Volume
41.55K
Average Volume (3m)
443.01K
1-Year Change
-95.43%
Book Value / Share
9.55
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REVB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
62.175
Upside
+2,368.24%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

Revelation Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Revelation Biosciences Inc Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Compare REVB to Peers and Sector

Metrics to compare
REVB
Peers
Sector
Relationship
P/E Ratio
−0.3x−3.9x−0.5x
PEG Ratio
-0.010.00
Price/Book
1.3x3.3x2.6x
Price / LTM Sales
-153.9x3.3x
Upside (Analyst Target)
-147.3%43.5%
Fair Value Upside
Unlock2.1%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 62.175
(+2,368.24% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-6.33 / -9.00
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

REVB Income Statement

People Also Watch

17.74
SRPT
+9.10%
0.579
WINT
+3.19%
9.1950
CYCC
+24.09%
5.7650
BGLC
-0.43%
0.384
ADIL
-6.88%

FAQ

What Stock Exchange Does Revelation Biosciences Trade On?

Revelation Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Revelation Biosciences?

The stock symbol for Revelation Biosciences is "REVB."

What Is the Revelation Biosciences Market Cap?

As of today, Revelation Biosciences market cap is 3.84M.

What Is Revelation Biosciences's Earnings Per Share (TTM)?

The Revelation Biosciences EPS (TTM) is -108.79.

From a Technical Analysis Perspective, Is REVB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Revelation Biosciences Stock Split?

Revelation Biosciences has split 4 times.

How Many Employees Does Revelation Biosciences Have?

Revelation Biosciences has 9 employees.

What is the current trading status of Revelation Biosciences (REVB)?

As of 07 Aug 2025, Revelation Biosciences (REVB) is trading at a price of 2.52, with a previous close of 2.50. The stock has fluctuated within a day range of 2.42 to 2.60, while its 52-week range spans from 2.11 to 168.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.